For those who want to join a psychedelic clinical trial, psychedelic therapy session, or psychedelic retreat, you have to be a legal adult. For many clinicians, therapists, and retreat organisers, this means you have to be at least 18, although a small number of retreats restrict their services only to those 25 years and older.…
View Post
Intergenerational trauma (also known as generational trauma or ancestral trauma) refers to the idea that trauma can be passed down through the generations, affecting those who didn’t directly experience it. It is the notion that unresolved traumas, pain, and suffering experienced by past generations influence the emotional well-being of those who exist today. Examples of…
View Post
It’s easy to find glowing accounts of microdosing. On psychedelic-related subreddits and forums, on social media, on blogs, and in real-life psychedelic circles, many people report incredible, life-changing, and wide-ranging benefits from taking tiny, sub-perceptual doses of psychedelics (typically psilocybin mushrooms and LSD). Despite reports of persistent depression fading away, not needing psychiatric medications anymore,…
View Post
In psychedelic clinical trials, patients with a history of psychotic experiences, a psychotic disorder like schizophrenia, or a mood disorder with psychotic symptoms are typically screened out. (Other exclusion criteria – again, typically – include a diagnosis of bipolar disorder or recent suicidality.) The reason for excluding people with psychotic symptoms from trials on psychedelic-assisted therapy…
View Post
Unlike many other substances, psychedelics can create a lingering feeling of well-being, long after the altered state of consciousness has subsided. This is known as an ‘afterglow’. Drugs like cocaine, amphetamine, methamphetamine, and (for many) MDMA are associated with ‘comedowns’. When the high fades after the use of these drugs, you may be left with…
View Post